Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 10 of 10 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/15/22
End: 03/22/24
Due: 03/22/25
Phase: N/A
Priority: Normal
Start: 07/05/17
End: 09/26/20
Due: 09/26/21
Phase: N/A
Priority: Normal
Start: 04/03/23
End: 03/14/24
Due: 03/14/25
Phase: N/A
Priority: Normal
Start: 11/30/23
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 03/14/22
End: 03/16/23
Due: 03/16/24
Phase: N/A
Priority: Normal
Start: 11/08/22
End: 08/15/23
Due: 08/15/24
Phase: N/A
Priority: Normal
Start: 06/07/22
End: 07/25/24
Due: 07/25/25
Phase: N/A
Priority: Normal
Start: 09/19/23
End: 02/06/24
Due: 02/06/25
Phase: N/A
Priority: Normal
Start: 12/24/24
End: 02/18/25
Due: 02/18/26
Phase: N/A
Priority: Normal
Start: 12/04/17
End: 03/12/20
Due: 03/12/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Optina Eye to Heart Connection | NCT05199428 | Optina Diagnostics Inc. | user2@example.com | None | 2022-06-15 | 2024-03-22 | 2025-03-22 | - | - | 2025-07-14 |
| Retinal Metabolic Imaging in a Diverse Population | NCT03442816 | Optina Diagnostics Inc. | user2@example.com | None | 2017-07-05 | 2020-09-26 | 2021-09-26 | - | - | 2025-07-14 |
| Retinal Deep PhenotypingTM | NCT05903651 | Optina Diagnostics Inc. | user2@example.com | None | 2023-04-03 | 2024-03-14 | 2025-03-14 | - | - | 2025-07-14 |
| Retinal Deep Phenotyping.TM | NCT05903664 | Optina Diagnostics Inc. | user2@example.com | None | 2023-11-30 | 2024-07-31 | 2025-07-31 | - | - | 2025-07-14 |
| Eye to Brain Connection | NCT05215782 | Optina Diagnostics Inc. | user2@example.com | None | 2022-03-14 | 2023-03-16 | 2024-03-16 | - | - | 2025-07-14 |
| Hyperspectral Drusen Classification | NCT06860555 | Optina Diagnostics Inc. | user2@example.com | None | 2022-11-08 | 2023-08-15 | 2024-08-15 | - | - | 2025-07-14 |
| Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test | NCT05107882 | Optina Diagnostics Inc. | user2@example.com | None | 2022-06-07 | 2024-07-25 | 2025-07-25 | - | - | 2025-07-14 |
| RDP Reliability Study | NCT06057493 | Optina Diagnostics Inc. | user2@example.com | None | 2023-09-19 | 2024-02-06 | 2025-02-06 | - | - | 2025-07-14 |
| The GA in HSI Study | NCT06860568 | Optina Diagnostics Inc. | user2@example.com | None | 2024-12-24 | 2025-02-18 | 2026-02-18 | - | - | 2025-07-14 |
| Retinal Metabolic Imaging of Alzheimer Patient | NCT03420807 | Optina Diagnostics Inc. | user2@example.com | None | 2017-12-04 | 2020-03-12 | 2021-03-12 | - | - | 2025-07-14 |